guidance.fyi
Company, ticker, metric, guidance, or anything said
VerifiedNumbers checked and claims independently audited

Q1 FY27 concall · earnings callSigachi Industries Ltd

Sigachi reported steady Q1 results with improved MCC realizations and is progressing on capacity expansions while targeting a significant revenue ramp-up and margin improvement for the full year.

Positive tone4-minute briefPublished 7 days after the call

Numbers
MetricThis quarterChangeFive-quarter trend
Total Operating Income₹121.27 Cr—
EBITDA₹16.5 Cr—
EBITDA Margin13.6%—
Net Profit₹8.14 Cr—
PAT Margin6.76%—
MCC Revenue₹82.74 Cr—
O&M Revenue₹13.06 Cr—
API Revenue₹21.68 Cr—
Financials

From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.

QuarterRevenueNet profit (PAT)Basic EPS
Q3 FY25₹139.42 Cr+25.7% YoY+11.6% QoQ₹20.51 Cr+27.3% YoY-2.4% QoQ₹0.65+27.5% YoY-1.5% QoQ
Q2 FY25₹124.90 Cr+25.9% YoY+30.5% QoQ₹21.02 Cr+39% YoY+64.7% QoQ₹0.66-86.6% YoY+65% QoQ
Q1 FY25₹95.71 Cr+13% YoY-8.1% QoQ₹12.76 Cr+17.3% YoY-15.9% QoQ₹0.40-88.7% YoY-16.7% QoQ
Q4 FY24₹104.13 Cr+43.8% YoY-6.1% QoQ₹15.17 Cr+107.2% YoY-5.8% QoQ₹0.48-79.8% YoY-5.9% QoQ
Q3 FY24₹110.95 Cr+61.1% YoY+11.9% QoQ₹16.11 Cr+64.1% YoY+6.5% QoQ₹0.51-84.1% YoY-89.7% QoQ
TL;DR
  • Q1 revenue was INR121.27 crores with EBITDA of INR16.5 crores (13.6% margin) and PAT of INR8.14 crores.
  • MCC capacity expansion to 30,000 MTPA is on track for Q2 FY28, and a new CCS facility is under development.
  • Management reiterated full-year revenue guidance of INR650-675 crores and an 18% EBITDA margin target.
  • MCC average realization improved to INR241.36 per kg from INR216 per kg in the previous quarter.
  • The company expects to settle a significant insurance claim by September 2026.
Said on the call

“We enter FY27 with a clear focus, execution, innovation and creating sustainable value.”

Amit Raj Sinha, Managing Director and CEO
From the Q&A
TopicWhat management said
MCC Demand and PricingManagement stated MCC realizations increased to INR241.36/kg from INR216/kg last quarter, citing quality and regulatory compliance as key differentiators, and expects the Asia Pacific market to grow at 7-8% CAGR.
Capacity Expansion and UtilizationThe 12,000 MTPA MCC expansion at Dahej-2 is on schedule for Q2 FY28. Current MCC capacity is 18,000 MTPA, with utilization at 76.8% in Q1; management expects to reach ~95% utilization by year-end through debottlenecking.
Full-Year GuidanceManagement reaffirmed revenue guidance of INR650-675 crores and an 18% EBITDA margin for FY27, expecting a ramp-up in subsequent quarters, particularly in API and O&M segments.
Insurance ClaimThe insurance claim for a past incident is under assessment; the company expects to receive the full claim (with a possible discount) or an ad-hoc amount by September 2026.
API Business Ramp-upAPI revenue was INR21.68 crores in Q1; management expects it to grow with new molecules like Sparsentan and Bempedoic Acid, targeting over INR100 crores for the full year.
CCS ProjectThe 1,800 ton Croscarmellose Sodium (CCS) facility at Dahej SEZ is under development, targeting FY28 commissioning. Management expects CCS margins to be 'far more healthier' than MCC, potentially above 25%, and is already receiving inquiries from export customers.
Capital Expenditure and FundingCapex planned is over INR100 crores in FY27 and INR150-200 crores in FY28, to be funded via a mix of debt (the company is currently debt-free) and potential equity/preferential issue.
Guidance
  • Revenue guidance of INR650-675 crores for FY27.
  • Full-year EBITDA margin target of 18%.
  • Dahej-2 MCC capacity expansion (12,000 MTPA) targeted for commissioning in Q2 FY28.
  • Expect to receive insurance claim settlement (full or ad-hoc) by September 2026.
  • API business expected to contribute over INR100 crores in FY27.
  • CCS facility (1,800 tons) commissioning targeted for FY28.
Source
Same sector

Others in Chemicals

All Chemicals →
  • Prasol Chemicals LimitedQ1 FY27Positive tone

    Q1 FY27 was exceptionally strong on inventory gains from West Asia-led acetone price rises, while underlying mid-single-digit volume growth remained healthy and management guided for INR1,550 crores to INR1,650 crores revenue in FY27 with normalization of margins ahead.

    Revenue from operations - Q1 FY27
    ₹433.6 Cra growth of 35.7% YoY
    Gross margin - Q1 FY27
    37.9%compared to 30% in Q1 FY26
    PRASOLCHEMChemicalsVerified brief5 guidance items
  • Solar Industries India LimitedQ1 FY27Positive tone

    Solar Industries agreed to acquire South Africa's Omnia Holdings for cash funded by debt and internal accruals to build an integrated global explosives and blasting solutions platform with backward integration into ammonium nitrate.

    Solar projected current year revenue
    ₹14,000 Cr
    Solar projected FY28 revenue
    ₹16,500 Cr
    SOLARINDSChemicalsVerified brief4 guidance items
  • Indo Borax & Chemicals LimitedQ1 FY27Positive tone

    Q1 FY27 delivered 31.34% revenue growth and 59.31% profit growth from better utilization and realizations while Indo Borax moved to acquire 64.26% of Kronox Lab Sciences.

    Operating revenue
    ₹70.36 Cr+31.34% increase against ₹53.57 Cr in Q1 FY 26
    EBITDA
    ₹19.8 Crup by 62.16% vs ₹12.21 Cr in Q1 FY 26
    INDOBORAXChemicalsVerified brief5 guidance items
  • Stallion India started FY27 with strong profit growth and is focusing on executing key expansion projects, including its high-purity helium and R32 manufacturing facilities, to drive future growth.

    Total Revenue
    124.68 crores12.78%
    EBITDA
    25.27 crore75.85%
    STALLIONChemicalsVerified brief4 guidance items
  • Ester Industries LimitedQ1 FY27Positive tone

    The quarter was driven by a strong rebound in the BOPET film business due to improved industry pricing and capacity utilization, leading to a significant turnaround in consolidated profitability.

    Consolidated Total Income
    ₹441.9 Cr27.4%
    Consolidated EBITDA
    ₹58.9 Cr103.4%
    ESTERChemicalsVerified brief4 guidance items